Practical compendium of antiarrhythmic drugs: a clinical consensus statement of the European Heart Rhythm Association of the European Society of Cardiology

EP Europace Journal

30 March 2025
Organised by: Logo
ESC Journals ARRHYTHMIAS AND DEVICE THERAPY CARDIOVASCULAR PHARMACOLOGY Arrhythmias, General Atrial Fibrillation (AF) Device Therapy Supraventricular Tachycardia (Non-Atrial Fibrillation) Syncope and Bradycardia

Abstract

Abstract

The European Heart Rhythm Association Practical Compendium of Anti-arrhythmic Drugs (AADs) offers advice on these drugs, focusing on their clinical use and the global impact of cardiac arrhythmias. This document aims to provide practical instructions to clinicians in arrhythmia management through pharmacological strategies. The compendium highlights persistent challenges in arrhythmia treatment, including clinical constraints, procedural risks, and the complexity of certain arrhythmias. Notably, atrial fibrillation is highly prevalent, and the demand for invasive treatment often surpasses the capacity of existing healthcare systems. As a result, pharmacological management remains essential. This is particularly relevant for patients with cardiac implantable electronic devices or channelopathies, where ablation is often not a suitable option. Anti-arrhythmic drugs play a pivotal role in these scenarios. The compendium introduces the ABC framework for AAD therapy: A (Appropriate therapy), for patients in whom AADs are the best therapeutic option; B (Backup therapy), as adjunctive treatment to invasive procedures, such as catheter ablation; and C (Complementary therapy), in combination with other therapies. The document provides detailed insights into the mechanisms of action, efficacy, safety profiles, and drug interactions of each class of AADs. Additionally, the compendium covers practical considerations, including initiation, combination strategies, monitoring, follow-up, special populations, and adverse effect management, with an emphasis on pro-arrhythmia risk mitigation. It also explores the integration of AADs with other therapeutic modalities, promoting a synergistic approach to optimize patient outcomes. In summary, this compendium serves as an indispensable resource for clinicians, offering practical advice and evidence-based insights to navigate the complexities of arrhythmia management effectively.

Contributors

Jose L Merino
Jose L Merino

Author

La Paz University Hospital Madrid , Spain

Juan Tamargo
Juan Tamargo

Author

Complutense University of Madrid Madrid , Spain

Carina Blomström-Lundqvist
Carina Blomström-Lundqvist

Author

Orebro University Hospital Orebro , Sweden

Giuseppe Boriani
Giuseppe Boriani

Author

Modena Polyclinic Modena University Hospital Modena , Italy

Harry J G M Crijns
Harry J G M Crijns

Author

Cardiovascular Research Institute Maastricht (CARIM) Maastricht , Netherlands (The)

James A Reiffel
James A Reiffel

Author

Columbia University Medical Centre New York , United States of America

Jacob Tfelt-Hansen
Jacob Tfelt-Hansen

Author

Rigshospitalet - Copenhagen University Hospital Copenhagen , Denmark

A John Camm
A John Camm

Author

City St George's University of London London , United Kingdom of Great Britain & Northern Ireland

ESC 365 is supported by